JD LAB (0774.448.592): financials and annual accounts

JD LAB

Trooz ·KBO/BCE: BE 0774.448.592

Line	2025	2024	2023	2022
Balance sheet: assets
Total assets`20/58`	720,894	482,440	309,934	201,663
Formation expenses`20`	489	1,077	1,665	2,253
Fixed assets`21/28`	1,289	2,240	3,334	1,557
Tangible fixed assets`22/27`	1,289	2,240	3,334	1,557
Furniture and vehicles`24`	1,289	2,240	3,334	1,557
Current assets`29/58`	719,116	479,123	304,936	197,854
Amounts receivable within one year`40/41`	255,566	123,503	117,672	108,239
Trade receivables`40`	237,240	120,714	116,939	108,239
Other amounts receivable`41`	18,326	2,789	734	-
Current investments`50/53`	241,196	155,716	-	-
Cash at bank and in hand`54/58`	220,533	198,119	185,477	89,615
Deferred charges and accrued income`490/1`	1,820	1,785	1,787	-
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	720,894	482,440	309,934	201,663
Equity`10/15`	465,197	465,197	288,832	163,364
Contributions`10/11`	3,000	3,000	3,000	3,000
Reserves`13`	462,197	462,197	285,832	160,364
Distributable reserves`133`	462,197	462,197	285,832	160,364
Amounts payable`17/49`	255,696	17,242	21,103	38,298
Amounts payable within one year`42/48`	255,696	17,242	21,103	38,298
Trade debts`44`	6,303	1,216	87	1,997
Suppliers`440/4`	6,303	1,216	87	1,997
Taxes, remuneration and social security`45`	6,600	9,357	2,307	25,782
Taxes`450/3`	6,600	9,357	2,307	25,782
Other amounts payable`47/48`	242,793	6,670	18,709	10,520
Income statement
Gross operating margin`9900`	297,848	233,743	179,950	230,313
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	1,539	1,682	1,448	830
Other operating charges`640/8`	500	484	124	-
Operating profit (loss)`9901`	295,809	231,578	178,378	229,484
Financial income`75/76B`	6,647	0	-	-
Recurring financial income`75`	6,647	0	-	-
Financial charges`65/66B`	405	2,744	603	238
Recurring financial charges`65`	405	2,744	603	238
Profit (loss) for the period before taxes`9903`	302,051	228,834	177,775	229,246
Income taxes`67/77`	69,211	52,468	52,307	68,882
Profit (loss) for the period`9904`	232,840	176,366	125,467	160,364
Profit (loss) for the period to be appropriated`9905`	232,840	176,366	125,467	160,364
Appropriation of the result
Profit (loss) to be appropriated`9906`	232,840	176,366	125,467	160,364
Transfer to equity`691/2`	-	176,366	125,467	160,364
To other reserves`6921`	-	176,366	125,467	160,364
Profit to be distributed`694/7`	232,840	-	-	-
Return on contributions (dividend)`694`	232,840	-	-	-
Document	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	10-06-2026	2026-00162209	PDF
31-12-2024	micro format	14-07-2025	2025-00266485	PDF
31-12-2023	micro format	11-07-2024	2024-00241580	PDF
31-12-2022	micro format	13-07-2023	2023-00236605	PDF

Line	2025	2024	2023	2022
EBITDA	297,348	233,260	179,826	230,313
Cash flow	234,380	178,047	126,916	161,194
Investment in fixed assets (approximation)	588	588	2,638	1,699
Change in cash	22,414	12,643	95,862	-
Working capital	463,420	461,880	283,833	159,555
Solvency	64.5%	96.4%	93.2%	81.0%
Current ratio	2.81	27.79	14.45	5.17
Debt to equity	0.55	0.04	0.07	0.23
ROE	50.1%	37.9%	43.4%	98.2%
ROA	32.3%	36.6%	40.5%	79.5%
Interest coverage	over 100	85.01	over 100	over 100

Item	2025	2024	2023	2022
Tangible fixed assets	-	-	€2,638	€1,699
Depreciation and write-downs of the year	€1,539	€1,682	€1,448	€830

JD LAB

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on JD LAB

Next steps